TCT 747: A Multidisciplinary Team Approach to Improve Outcomes of Percutaneous Coronary Intervention

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Terumo Medical Corporation; Edwards Lifesciences; Medtronic